Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model.
about
Retina Is Protected by Neuroserpin from Ischemic/Reperfusion-Induced Injury Independent of Tissue-Type Plasminogen ActivatorOcriplasmin: who is the best candidate?The predictability of ocriplasmin treatment effects: is there consensus among retinal experts? Results from the EXPORT study.Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions.Ocular Safety of Intravitreal Connective Tissue Growth Factor Neutralizing Antibody.
P2860
Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Increased retinal toxicity of ...... retinal vein occlusion model.
@ast
Increased retinal toxicity of ...... retinal vein occlusion model.
@en
Increased retinal toxicity of ...... retinal vein occlusion model.
@nl
type
label
Increased retinal toxicity of ...... retinal vein occlusion model.
@ast
Increased retinal toxicity of ...... retinal vein occlusion model.
@en
Increased retinal toxicity of ...... retinal vein occlusion model.
@nl
prefLabel
Increased retinal toxicity of ...... retinal vein occlusion model.
@ast
Increased retinal toxicity of ...... retinal vein occlusion model.
@en
Increased retinal toxicity of ...... retinal vein occlusion model.
@nl
P2093
P1476
Increased retinal toxicity of ...... l retinal vein occlusion model
@en
P2093
Mihoko Suzuki
Motohiro Kamei
Takuhiro Yamamoto
Yasuo Tano
P2888
P304
P356
10.1007/S00417-007-0670-X
P577
2007-10-25T00:00:00Z
P6179
1041666033